Sponsor
Nuvectis Pharma Inc.
1 Bridge Plaza North Floor 2, 07024-7586, United States
About the sponsor
Research activity is centered on platinum-resistant ovarian carcinoma with ARID1A mutation, including disease arising in the fallopian tube and primary peritoneum. The sponsor’s clinical interest is concentrated on difficult-to-treat gynecologic cancers with limited treatment options.
- Platinum-resistant ovarian carcinoma
- ARID1A-mutated malignancy
- Fallopian tube carcinoma
- Primary peritoneal carcinoma
The sponsored program reflects a focused therapeutic commitment to oncology, especially molecularly defined gynecologic tumor subtypes.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.